Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1064303

registered interest
date	20/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Health Professions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that the Health Education England phase two cancer workforce plan co-ordinates with the workforce implementation plan in the NHS Long Term Plan.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	223778
answer	answer is ministerial correction date of answer 26/02/2019 answer text <p>Health Education England (HEE) published its first ever Cancer Workforce Plan in December 2017. HEE intended to publish a second phase, longer-term strategy that looked at the cancer workforce needs beyond 2021. This work was started and stakeholders from within the National Health Service and the charitable sector contributed to the early discussions. This work has since been superseded by publication of the NHS Long Term Plan in January 2019.</p><p> </p><p>My Rt. hon. Friend Secretary of State for Health and Social Care has subsequently commissioned Baroness Dido Harding, working closely with Sir David Behan, to lead a number of programmes to engage with key NHS interests to develop a detailed workforce implementation plan. These programmes will consider detailed proposals to grow the workforce rapidly, including staff working on cancer, consider additional staff and skills required, build a supportive working culture in the NHS and ensure first rate leadership for NHS staff.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 26/02/2019 12:17:17 answering member 4067 label Biography information for Steve Brine
tabling member	4433 label Biography information for Thangam Debbonaire

1064309

registered interest
date	20/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radioisotopes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what representations he has received on alternative arrangements for breast cancer diagnostic and treatment procedures in the event that there is a shortage of radioisotopes in the UK.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	223789
answer	answer is ministerial correction date of answer 28/02/2019 answer text <p>A search of the Department’s Ministerial correspondence database has identified one item of correspondence received since 1 August 2018 about alternative arrangements for breast cancer diagnostic and treatment procedures in the event that there is a shortage of radioisotopes in the United Kingdom. This figure represents correspondence received by the Department’s Ministerial correspondence unit only.</p><p> </p><p>We fully recognise that radioisotopes are vitally important to many people in this country including breast cancer patients. HM Revenue and Customs already has a process to identify ‘urgent goods’, such as medical radioisotopes, requiring faster handling to move through customs and border checks promptly. The Department has well established processes to manage and mitigate the small number of medicines shortages that may arise due to manufacturing or distribution issues. These processes include radioisotopes used in breast cancer diagnostic and treatment procedures.</p><p> </p><p>From January 2019, it became a mandatory requirement that the pharmaceutical industry must report this information to the Department in a timely manner. Following notification and risk assessment, the Department’s medicine supply team will continue to work behind the scenes with relevant stakeholders and use a host of tools to help mitigate and prevent an issue from impacting patients including the consideration of alternative treatment options. The Department is not aware of any significant radioisotope shortages that are currently affecting breast cancer patients.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 224533 question first answered 28/02/2019 11:47:48 answering member 1585 label Biography information for Stephen Hammond
tabling member	4433 label Biography information for Thangam Debbonaire

1064781

registered interest
date	20/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radioisotopes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential effect of a shortage of radioisotopes on the number of breast cancer diagnostic and treatment procedures.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	224533
answer	answer is ministerial correction date of answer 28/02/2019 answer text <p>A search of the Department’s Ministerial correspondence database has identified one item of correspondence received since 1 August 2018 about alternative arrangements for breast cancer diagnostic and treatment procedures in the event that there is a shortage of radioisotopes in the United Kingdom. This figure represents correspondence received by the Department’s Ministerial correspondence unit only.</p><p> </p><p>We fully recognise that radioisotopes are vitally important to many people in this country including breast cancer patients. HM Revenue and Customs already has a process to identify ‘urgent goods’, such as medical radioisotopes, requiring faster handling to move through customs and border checks promptly. The Department has well established processes to manage and mitigate the small number of medicines shortages that may arise due to manufacturing or distribution issues. These processes include radioisotopes used in breast cancer diagnostic and treatment procedures.</p><p> </p><p>From January 2019, it became a mandatory requirement that the pharmaceutical industry must report this information to the Department in a timely manner. Following notification and risk assessment, the Department’s medicine supply team will continue to work behind the scenes with relevant stakeholders and use a host of tools to help mitigate and prevent an issue from impacting patients including the consideration of alternative treatment options. The Department is not aware of any significant radioisotope shortages that are currently affecting breast cancer patients.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 223789 question first answered 28/02/2019 11:47:49 answering member 1585 label Biography information for Stephen Hammond
tabling member	4433 label Biography information for Thangam Debbonaire